Stay Updated
Press Releases
IN THEIR OWN WORDS: Drug Corporations Plan to Raise Prices on COVID-19 Vaccines
WASHINGTON, DC — This week, Moderna became the latest drug company to announce plans to increase the price of its COVID-19 vaccine once public attention on the novel coronavirus subsides. This would normally be considered business as usual, but it’s especially appalling because these developing COVID-19 vaccines have been financed by taxpayers. Experts anticipate a […]
Press Releases
Moderna Makes Martin Shkreli Blush
WASHINGTON, DC — It’s been a banner day for the new face of drug corporation greed, the Boston biotech company Moderna. First, the drug company admitted its COVID-19 vaccine development is 100 percent funded by U.S. taxpayers. Then, Moderna’s CEO announced plans to price the company vaccine at $32 to $37 per dose — the highest […]
Press Releases
WASHINGTON, DC — In light of the news that Moderna plans to price its COVID-19 contender at $50 to $60 per course of treatment, Ben Wakana, the executive director of Patients For Affordable Drugs, issued the following statement: “It’s brazen and disgraceful that Moderna plans to take advantage of a tragedy. Moderna priced its vaccine […]
Press Releases
WASHINGTON, DC — Today, Pfizer confirmed what patients across the country already know: The company continues to put profits over patients. In announcing a deal with the U.S. government, Pfizer revealed it will charge American taxpayers $1.95 billion for 100 million doses of its upcoming vaccine — revealing a price of nearly $20 per dose. “It’s […]
Press Releases
New Video Highlights Patients’ Struggle to Afford Prescriptions During COVID-19
WASHINGTON, DC — In a new video, patients from across the country deliver a clear message: The COVID-19 pandemic hasn’t made the issue of high drug prices go away, it has made it worse. As millions of Americans have lost jobs and health insurance during the pandemic and pharmaceutical manufacturers continue to raise prices of […]
Press Releases
Statement on Gilead's Remdesivir Price
WASHINGTON, DC — In response to Gilead’s pricing announcement for remdesivir, Patients For Affordable Drugs Executive Director Ben Wakana issued the following statement: “Today’s news proves that Gilead aims to profiteer off the COVID-19 pandemic. Gilead will realize profits far in excess of its cost to develop and produce a drug that has yet to demonstrate […]
Press Releases
NEW REPORT: Big Pharma Hikes Drug Prices in Midst of COVID-19 Crisis
WASHINGTON, DC –– According to a new analysis by Patients For Affordable Drugs, drug companies raised the list prices of 245 drugs by an average of 23.8 percent since the first case of the novel coronavirus in the U.S. was reported in January. The research found that 75 percent of those price hikes were drugs […]
Press Releases
New Video Makes Case For Affordable COVID-19 Drugs
WASHINGTON, DC –– In a video released today, Patients For Affordable Drugs juxtaposes the history of polio vaccine development in the 1950s with the current race to develop a COVID-19 vaccine. While polio vaccine inventor Jonas Salk refused to profit off of his life-saving creation, modern day pharmaceutical companies stand to reap huge profits on […]